Safety of biweekly a1-antitrypsin treatment in the RAPID programme

Timm Greulich, Jan Chlumsky, Marion Wencker, Oliver Vit, Michael Fries, Thomas Chung, Amgad Shebl, Claus Vogelmeier, Kenneth R. Chapman, Noel G. McElvaney

Source: Eur Respir J, 52 (5) 1800897; 10.1183/13993003.00897-2018
Journal Issue: November
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Timm Greulich, Jan Chlumsky, Marion Wencker, Oliver Vit, Michael Fries, Thomas Chung, Amgad Shebl, Claus Vogelmeier, Kenneth R. Chapman, Noel G. McElvaney. Safety of biweekly a1-antitrypsin treatment in the RAPID programme. Eur Respir J, 52 (5) 1800897; 10.1183/13993003.00897-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: